Rigel Resource Acquisition Corp (RRAC) recently announced the postponement of its extraordinary general meeting scheduled for February 13, 2025. The meeting has been rescheduled to February 28, 2025, ...
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), a biotech company with a market capitalization of $427 million and currently trading at $24.39, recently reported that Dean Schorno, the company's Executive ...
Singapore-based Rigel Capital is set to announce the final close of its first early-stage fund, Rigel Star, at slightly over $40 million soon, pushing the total capital the firm has raised across its ...
Although not often, unsafe gun storage can result in tragic accidents that weigh on first responders and families. “One of ...
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer ...
Rigel will mail the definitive proxy statement/prospectus to shareholders of record as of the close of business on January 10, 2025. Rigel will hold its Extraordinary General Meeting (the ...
SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating the safety ...
SOUTH SAN FRANCISCO, Calif., Jan. 9, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback